Williams B, Mancia G, Spiering W, et al. 2018 ESC/EHS Guidelines for the management of arterial hypertension. Eur Heart J 2018; doi.10.1093/eurheartj/ehy339.
Wald DS, Law M, Morris JK, et al. Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials. Am J Med 2009; 122(3): 290-300.Go to original source...Go to PubMed...
Bangalore S, Kamalakkannan G, Parkar S, Messerli FH. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med 2007; 120(8): 713-719.Go to original source...Go to PubMed...
Simons LA, Chung E, Ortiz M: Long-term persistence ITL single-pill, fixed-dose combination therapy versus two pills of amlodipin and perindopril for hypertension: Australian experience. Curr Med Res Opin 2017; 33: 1783-1787.Go to original source...Go to PubMed...
Rea F, Corrao G, Merlino L, Mancia G: Early cardiovascular protection by initial two-drug fixed - dose combination treatment vs. monotherapy in hypertension. Euro Heart J 2018; 39: 3654-3661.Go to original source...Go to PubMed...
Doporučení pro diagnostiku a léčbu arteriální hypertenze ČSH 2017 [online]. Dostupné z: http://www.hypertension.cz/doporuceni-a-prakticke-postupy-csh-1404042002.html
Dahlöf B, Sever PS, Poulter NR, et al. ASCOT Investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial.Lancet. 2005; 366(9489): 895-906.Go to original source...Go to PubMed...
Jamerson K, Weber MA, Bakris GL, et al. ACCOMPLISH Trial Investigators. Benazepril plus amlodipine or hydrochlorthiazide for hypertension in high-risk patients. N Engl J Med. 2008; 359: 2417-2428.Go to original source...Go to PubMed...
Gupta A, Mackay J, Whitehouse A, et al. Long-term mortality after blood pressure-lowering and lipid-lowering treatment in patients with hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial Legacy study: 16 - year follow-up results of a randomized factorial trial. Lancet 2018; 392: 1127-1137.Go to original source...Go to PubMed...
Madam, Sir, please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert). Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.
I declare:
that I have met the above instruction
I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited